AU510679B2 - Polypeptides for treating schizophrenia - Google Patents

Polypeptides for treating schizophrenia

Info

Publication number
AU510679B2
AU510679B2 AU23174/77A AU2317477A AU510679B2 AU 510679 B2 AU510679 B2 AU 510679B2 AU 23174/77 A AU23174/77 A AU 23174/77A AU 2317477 A AU2317477 A AU 2317477A AU 510679 B2 AU510679 B2 AU 510679B2
Authority
AU
Australia
Prior art keywords
polypeptides
treating schizophrenia
schizophrenia
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU23174/77A
Other languages
English (en)
Other versions
AU2317477A (en
Inventor
C. E Frohman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stateof Michigan
Original Assignee
State of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/772,851 external-priority patent/US4146614A/en
Application filed by State of Michigan filed Critical State of Michigan
Publication of AU2317477A publication Critical patent/AU2317477A/en
Application granted granted Critical
Publication of AU510679B2 publication Critical patent/AU510679B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU23174/77A 1976-03-23 1977-03-11 Polypeptides for treating schizophrenia Expired AU510679B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66952676A 1976-03-23 1976-03-23
USUS669526 1976-03-23
USUS772351 1977-02-28
US05/772,851 US4146614A (en) 1976-03-23 1977-02-28 Threonyl-valyline leucine containing peptides and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
AU2317477A AU2317477A (en) 1978-09-14
AU510679B2 true AU510679B2 (en) 1980-07-10

Family

ID=27100128

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23174/77A Expired AU510679B2 (en) 1976-03-23 1977-03-11 Polypeptides for treating schizophrenia

Country Status (13)

Country Link
JP (1) JPS52142015A (pt)
AU (1) AU510679B2 (pt)
CA (1) CA1103239A (pt)
DE (1) DE2712781A1 (pt)
DK (1) DK125177A (pt)
FR (1) FR2351954A1 (pt)
GB (1) GB1561247A (pt)
GR (1) GR63642B (pt)
LU (1) LU76998A1 (pt)
NL (1) NL7703124A (pt)
NO (1) NO771031L (pt)
NZ (1) NZ183627A (pt)
SE (1) SE7702925L (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU583578B2 (en) * 1984-12-14 1989-05-04 Australian Commercial Research & Development Limited Amino acid and peptide inhibitors of human leucocytic elastase

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU583578B2 (en) * 1984-12-14 1989-05-04 Australian Commercial Research & Development Limited Amino acid and peptide inhibitors of human leucocytic elastase

Also Published As

Publication number Publication date
NZ183627A (en) 1980-02-21
FR2351954B1 (pt) 1980-03-28
JPS52142015A (en) 1977-11-26
SE7702925L (sv) 1977-09-24
GR63642B (en) 1979-11-27
NL7703124A (nl) 1977-09-27
NO771031L (no) 1977-09-26
LU76998A1 (pt) 1977-10-03
GB1561247A (en) 1980-02-13
CA1103239A (en) 1981-06-16
DE2712781A1 (de) 1977-10-06
FR2351954A1 (fr) 1977-12-16
DK125177A (da) 1977-09-24
AU2317477A (en) 1978-09-14

Similar Documents

Publication Publication Date Title
PH16149A (en) Aminoalkyl substituted heterocycles
ZA776316B (en) Control means
CA1029834A (en) System for controlling two variables
JPS52110795A (en) Process for polyynnbutene
AU509113B2 (en) Rom-intializing apparatus
IL51429A (en) Coccidiocidal composition for treating
AU497355B2 (en) Spray apparatus for refractory material
AU520676B2 (en) Control circuits
AU510679B2 (en) Polypeptides for treating schizophrenia
AU514965B2 (en) Polypeptide derivatives
GB2025230B (en) Control circuits for electrosurgicaldevices
SU578093A1 (ru) Устройство дл очистки газа
SU644888A1 (ru) Устройство дл пропитки ткани
AU3087777A (en) Phoshating process
AU508751B2 (en) Azamethine-cu complex compounds
SU573157A1 (ru) Компрессионно-дистракционный аппарат
SU649490A1 (ru) Устройство дл обработки труб
SU587239A1 (ru) Устройство дл цементировани обсадных колонн
SU601191A1 (ru) Устройство дл ориентации предметов
SU625023A1 (ru) Устройство дл цементрировани обсадных колонн
SU592407A1 (ru) Устройство дл приготовлени кормов
SU615981A1 (ru) Устройство дл определени величины давлени металла на валки при деформировании металла рабочими валками
SU629966A1 (ru) Устройство дл дроблени материалов
AU512369B2 (en) Package-dispenser for mips
JPS52155383A (en) Aparratus for crossslinking